Navigation Links
ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Date:8/19/2007

looking statements that involve risks and assumptions that, if they materialize or do not prove to be accurate, could cause ADVENTRX's results to differ materially from historical results or those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the potential for CoFactor to receive regulatory approval for metastatic colorectal cancer or other indications on a timely basis or at all; the uncertain process of seeking regulatory approval; difficulties or delays in developing, testing, manufacturing and marketing of CoFactor; the risk that ADVENTRX will be unable to raise sufficient capital to fund the projects necessary to meet its anticipated or stated goals and milestones; the ability to timely enroll subjects in ADVENTRX's current and anticipated clinical trials; the timing and success of clinical trials; the potential for regulatory authorities to require additional preclinical work or other clinical requirements to support regulatory filings; adverse side effects or inadequate therapeutic efficacy of CoFactor; the risk that preclinical results are not indicative of the success of subsequent clinical trials and that products will not perform as preclinical and clinical data suggest or as otherwise anticipated; and other risks and uncertainties more fully described in ADVENTRX's press releases and periodic filings with the Securities and Exchange Commission. ADVENTRX's public filings with the Securities and Exchange Commission are available at http://www.sec.gov.

You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date when made. ADVENTRX does not intend to update any forward-looking statement, including as set forth in this press release, to reflect events or circumstances arising after the date on which it was made.


'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3

Related medicine technology :

1. ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic Testing of ANX-514 (Docetaxel Emulsion)
2. Adventrx Announces Positive Data From Multidrug Therapy With CoFactor
3. ADVENTRX to Present CoFactor Multiagent Therapy Data at AACR Annual Meeting
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Sygnis Pharma AG announces date for presentation of clinical results
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014 CVS Caremark Corporation ... of directors has approved a quarterly dividend of $0.275 (27.5 ... is payable on August 1, 2014, to holders of record ... CVS Caremark is dedicated to helping people on ... company in the United States . Through ...
(Date:1/15/2014)...  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the ... Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) ... in order to treat dental impairments, for tooth restoration ...
(Date:1/15/2014)... 2014 Massachusetts General Hospital (MGH), the Broad ... announced today that they have launched a strategic ... targets and develop novel therapies for inflammatory bowel ... worldwide. The MGH-Broad-Amgen collaboration brings together scientists with ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4
... , , JERUSALEM , ... Dr. Amatruda is the Former Senior Vice President and Franchise Head of,the ... Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB; http://www.oramed.com ), a,developer of oral ... Oramed,s Scientific Advisory Board, enhancing Oramed,s,talented and experienced scientific team. , ...
... , , MOUNTAIN VIEW, Calif. ... ) announced today that it will host an investor/analyst meeting on ... ET , in New York City . , The meeting will ... CEO, Alexza Pharmaceuticals James Cassella , PhD - ...
Cached Medicine Technology:Oramed Pharmaceuticals Expands Scientific Advisory Board With the Appointment of John Amatruda, M.D. 2Oramed Pharmaceuticals Expands Scientific Advisory Board With the Appointment of John Amatruda, M.D. 3Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 2Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 3Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 4
(Date:7/11/2014)... Riverside Health System became the first provider of ... 2012 and now, in partnership with Williamsburg Landing, will offer ... and Newport News region. , Also known as life care ... older adults who wish to remain in their homes but ... care services as well as control over the cost of ...
(Date:7/11/2014)... Pigments are insoluble colorants, which usually consist of ... coating, opacity, and coloring. These are water and oil ... substances such as paper, paints, plastics, and concrete. Binders ... impart color to the substance. Some examples of pigments ... , The coloring action of pigments is due to ...
(Date:7/11/2014)... Riviera Maya, Mexico (PRWEB) July 11, 2014 ... Mexico with the Mayan Heritage Experience Package at the ... Highlights of the package include a guided on-site ecological ... fauna, as well as The Coba Mayan Encounter Tour ... also climb Nohoch Muul, the tallest pyramid in the ...
(Date:7/11/2014)... Recently, Fadhits.com, the distinguished wedding dress manufacturer ... prom dresses . To bring more benefits to worldwide clients ... a special offer for these brand new items. Clients can ... company’s sales manager says gladly, “We are happy to announce ... to acknowledge all new and old customers and strengthen our ...
(Date:7/11/2014)... that people who have grown up on a farm ... urban counterparts to develop the most common inflammatory bowel ... have recently been published in the European Journal ... we can now see that not only allergic diseases, ... on the environment we are exposed to early in ...
Breaking Medicine News(10 mins):Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 2Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 3Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 4Health News:Americas Pigments Market Worth 1,099 Thousand MT by 2018 - New Report by MicroMarket Monitor 2Health News:Americas Pigments Market Worth 1,099 Thousand MT by 2018 - New Report by MicroMarket Monitor 3Health News:Explore the Aura and Mystery of the Yucatan’s Mayan Culture with New Hotel Package at AAA Five Diamond Grand Velas Riviera Maya 2Health News:Explore the Aura and Mystery of the Yucatan’s Mayan Culture with New Hotel Package at AAA Five Diamond Grand Velas Riviera Maya 3Health News:Promotion for Kids Prom Dresses Now Provided at Fadhits.com 2Health News:Growing up on a livestock farm halves the risk of inflammatory bowel diseases 2
... use of complementary and alternative medicine (CAM) in over 2000 ... from acupuncture to yoga - has increased in popularity since ... medicine has always been popular, although the type of therapies ... ,The greatest increase in popularity was in the transition ...
... found a cheap and non toxic method of treating Hepatitis, ... virus infects the liver, and in severe cases can lead ... through contact with the blood or body fluids of an ... HBV after a very bright and aware patient observed that ...
... gives powerful relief for chronic pain, and should be ... told a conference in Glasgow.,Dr William Notcutt of the ... cannabis extract used in his study - applied as ... in easing chronic pain. He announced the findings at ...
... Both drugs and surgery may be effective in treating Meniere's ... the hearing apparatus. A build up of pressure causes vertigo ... leads to hearing loss in the affected ear, and the ... ,This disease has a wide range of treatments available.Many ...
... form of arterial disease appear to have low levels of ... smoking habits. ,Peripheral artery disease (PAD) is a form of ... arteries and obstructs blood flow. In PAD, blood flow in ... and pain. PAD is also associated with an increased risk ...
... the number of miles you fly affects your risk of ... increase the risk of blood clotting in the veins of ... breaks off, it may travel to the lungs, forming a ... ,Researchers in France and the US have monitored all ...
Cached Medicine News:
Double-ended. Blunt and semi sharp 5 mm tips. Designated most popular model or size....
Double-ended. Designated most popular model or size....
Designated most popular model or size. Double-ended. 2 mm wide....
Desmarres Retractor Size 4...
Medicine Products: